Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Cancer Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Cancer Genetics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Cancer Genetics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Cancer Genetics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Cancer Genetics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Cancer Genetics Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
Cancer Genetics Acquires Assets of Response Genetics for USD14 Million 11
Partnerships 13
Cancer Genetics Enters into Partnership with Mendel Health 13
Cancer Genetics Enters into Agreement with Lantern Pharma 14
Cancer Genetics Partners with ApoCell for ApoStream 15
Cancer Genetics Partners with H3 Biomedicine 16
Cancer Genetics Enters into Distribution Agreement with Sayre Therapeutics 17
Cancer Genetics Enters into Co-Development Agreement with Columbia University Medical Center 18
Cancer Genetics Italia Enters Into Distribution Agreement With Nikon Instruments 19
Equity Offering 20
Cancer Genetics Prices USD7 Million in Private Placement of Units 20
Cancer Genetics Raises USD3 Million in First Tranche of Private Placement of Shares 21
Cancer Genetics to Raise USD5.5 Million in Private Placement of Shares and Warrants 22
Cancer Genetics Raises USD5 Million in Private Placement of Shares and Warrants 23
Cancer Genetics Raises USD12 Million in Public Offering of Shares 24
Cancer Genetics Completes Public Offering Of Shares For US$46 Million 26
Cancer Genetic Announces Public Offering Of Common Stock For Up To US$50 Million 28
Cancer Genetics Completes Underwriters’ Exercise Of Partial Over-Allotment Option For Public Offering Of Shares For US$16 Million 30
Cancer Genetics Completes IPO For US$7 Million 32
Cancer Genetics Inc – Key Competitors 34
Cancer Genetics Inc – Key Employees 35
Cancer Genetics Inc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Joint Venture 37
Recent Developments 38
Strategy And Business Planning 38
Apr 03, 2017: Cancer Genetics and Mendel Announce Strategic Partnership Enabling Artificial Intelligence in Precision Medicine to Drive Personalized Treatment and Accelerate Clinical Trial Matching for Cancer Care 38
Feb 05, 2016: Cancer Genetics Expands the Reach of Precision Medicine by Over 2.6 Million Individuals as it Signs a New Agreement With Blue Cross Blue Shield of Minnesota 39
Financial Announcements 40
Aug 14, 2017: Cancer Genetics Announces Second Quarter 2017 Financial Results, Accretive Acquisition and Capital Raise 40
May 11, 2017: Cancer Genetics Announces 15% Revenue Increase in First Quarter of 2017 over 2016 on Strong Organic Growth While Continuing on Path to Profitability 42
Mar 23, 2017: Cancer Genetics Announces Record Revenue for Fourth Quarter and Full-Year 2016 and Provides 2017 Business Update 44
Nov 10, 2016: Cancer Genetics Announces Strong Third Quarter with 68% Year over Year Revenue Growth and Highlights Path to Future Profitability 46
Aug 09, 2016: Cancer Genetics Reports Second Quarter 2016 Financial Results and Provides Company Updates 48
May 10, 2016: Cancer Genetics Announces 39% Revenue Increase and Provides Recent Company Highlights 50
Mar 10, 2016: Cancer Genetics Announces Strong Fourth Quarter and Full-Year 2015 Results and Provides 2016 Business Update 52
Corporate Communications 53
Nov 27, 2017: Cancer Genetics Appoints Renowned Biotech Entrepreneur Dr. Thomas F. Widmann to its Board of Directors 53
Feb 22, 2017: Cancer Genetics to Receive $1.0 Million in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program 54
Jun 27, 2016: Cancer Genetics Names Healthcare Technology Industry Veteran John Jay Roberts as COO and Executive Vice President of Finance 55
Product News 56
Dec 11, 2017: Cancer Genetics Advances Understanding of Immune Response and Measurement in Lymphomas by Combining PD-L1 Expression Analysis With RNA Analysis 56
Oct 30, 2017: Cancer Genetics a Leader in Personalized Medicine – Launches AntigenID, Solidifying CGI’s Position as a Precision Oncology Leader in the Fast Growing, Rapidly-Evolving Field of Immuno-Oncology Therapy & Drug Development 57
Sep 20, 2017: Cancer Genetics Announces 25th Contract Win to Provide Testing & Diagnostic Services for Combination Immuno-Oncology Clinical Trial 58
Jun 02, 2017: Cancer Genetics to Present at the 7th Annual LD Micro Invitational 59
Mar 13, 2017: Cancer Genetics to Present at “A Future Without Cancer Conference” on Friday, March 17 60
Jan 21, 2016: Cancer Genetics Launches Comprehensive Immuno-Oncology Testing Portfolio For Use in Clinical Trials, Translational Research, and Therapy Selection for Patients 61
Jan 06, 2016: Cancer Genetics to Present Results of Collaborative Renal Biopsy and Clear Cell Renal Cell Carcinoma Studies at the 2016 Genitourinary Cancer Symposium 62
Other Significant Developments 63
Jan 06, 2017: Cancer Genetics Announces Consolidation and Cost Reduction in Administrative and Operational Support Functions 63
Jun 02, 2016: Cancer Genetics Partners with ArcherDX to Offer Archer NGS Assays as a Sequencing Service for Biotech and Pharma 64
May 04, 2016: Cancer Genetics, Inc. Significantly Expands Marketshare In Immuno-Oncology Focused Clinical Trials With 12 Active Clinical Trials In Progress With Leading Biotech and Pharma Companies 65
Appendix 66
Methodology 66
About GlobalData 66
Contact Us 66
Disclaimer 66
Cancer Genetics Inc, Medical Equipment, Key Facts, 2016 2
Cancer Genetics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Cancer Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Cancer Genetics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Cancer Genetics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Cancer Genetics Inc, Deals By Market, 2011 to YTD 2017 9
Cancer Genetics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Cancer Genetics Acquires Assets of Response Genetics for USD14 Million 11
Cancer Genetics Enters into Partnership with Mendel Health 13
Cancer Genetics Enters into Agreement with Lantern Pharma 14
Cancer Genetics Partners with ApoCell for ApoStream 15
Cancer Genetics Partners with H3 Biomedicine 16
Cancer Genetics Enters into Distribution Agreement with Sayre Therapeutics 17
Cancer Genetics Enters into Co-Development Agreement with Columbia University Medical Center 18
Cancer Genetics Italia Enters Into Distribution Agreement With Nikon Instruments 19
Cancer Genetics Prices USD7 Million in Private Placement of Units 20
Cancer Genetics Raises USD3 Million in First Tranche of Private Placement of Shares 21
Cancer Genetics to Raise USD5.5 Million in Private Placement of Shares and Warrants 22
Cancer Genetics Raises USD5 Million in Private Placement of Shares and Warrants 23
Cancer Genetics Raises USD12 Million in Public Offering of Shares 24
Cancer Genetics Completes Public Offering Of Shares For US$46 Million 26
Cancer Genetic Announces Public Offering Of Common Stock For Up To US$50 Million 28
Cancer Genetics Completes Underwriters' Exercise Of Partial Over-Allotment Option For Public Offering Of Shares For US$16 Million 30
Cancer Genetics Completes IPO For US$7 Million 32
Cancer Genetics Inc, Key Competitors 34
Cancer Genetics Inc, Key Employees 35
Cancer Genetics Inc, Other Locations 36
Cancer Genetics Inc, Subsidiaries 36
Cancer Genetics Inc, Joint Venture 37